Abstract: Objective To explore the methods and significance of providing pharmaceutical care for lung cancer patients with chemotherapy-induced acute liver injury by clinical pharmacist. Methods By participating in drug therapy for a lung cancer patient with chemotherapy-induced acute liver injury, pay close attentions on the patients and make reasonable suggestions as to the adverse drug reactions to guarantee the rational use of drug. Clinical pharmacist provided pharmaceutical care such as selection of hepatoprotective drugs and the reapplication of drugs that cause acute liver injury for patients. Results Clinical pharmacists can assist clinicians to adjust the therapeutic regimen from the perspective of pharmacists, and improve the level of clinical drug treatment. Conclusion In clinical work, clinical pharmacists should play its due role in collaboration with clinicians actively, and carry out the monitoring of adverse drug reactions. In order to promote rational drug use and improve health treatment, we should take effective interventions.

Key words: chemotherapy, acute liver injury, clinical pharmacist, pharmaceutical care